| Application no. and date | 99303729.0 (espacenet) (Federated) (European Patent Register), 19990513 | | Patent/reg. no. and date | DK/EP 0956861, 20020424 | | Publication date | 19991117 | | Priority no. and date | US 79566, 19980515 | | EP pub. no. and date |
EP 0956861 19991117 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rayway, New Jersey 07065, US | | Applicant ref. no. | 106659 | | Inventor | Albrecht, Janice K., 1308 Temple Grove Court
Winter Park,
Florida 32789, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/7056 (2006.01) , A61K 38/21 (2006.01) , A61P 31/14 (2006.01) , A61K 31/7056 (2006.01) , A61K 38/21 (2006.01) | | Title | Kombinationsterapi omfattende ribavirin og interferon-alfa til patienter med kronisk hepatitis C infektion, der ikke har modtaget antiviral behandling | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
